WST11

DRUG4 trials

Sponsors

Steba Biotech S.A.

Conditions

CholangiocarcinomaNon-Small Cell Lung CancerProstate Cancer

Phase 2

Study of WST11 in Patients With Localized Prostate Cancer

CompletedNCT00707356

Steba Biotech S.A.Prostate Cancer

Start: 2008-09-30End: 2012-07-31Updated: 2016-04-19

Study Using WST11 in Patients With Obstructing Endobronchial Non-Small Cell Lung Cancer

TerminatedNCT00974662

Steba Biotech S.A.Non-Small Cell Lung Cancer

Start: 2009-09-30End: 2011-12-31Updated: 2015-04-28

Study Using WST11 in Patients With Localized Prostate Cancer

CompletedNCT00975429

Steba Biotech S.A.Prostate Cancer

Start: 2009-09-30End: 2012-08-31Updated: 2015-04-28

Study Using WST11 in Patients With Non-Resectable or Inoperable Cholangiocarcinoma

TerminatedNCT00975039

Steba Biotech S.A.Cholangiocarcinoma

Start: 2009-09-30End: 2012-09-30Updated: 2016-04-18